Ritter Daniher Financial Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Sell
2,597
-114
-4% -$9.2K 0.03% 166
2026
Q1
$235K Buy
2,711
+40
+1% +$3.83K 0.04% 149
2025
Q4
$257K Sell
2,671
-138
-5% -$13.4K 0.04% 147
2025
Q3
$268K Buy
2,809
+2,671
+1,936% +$246K 0.05% 140
2025
Q2
$12K Sell
138
-15
-10% -$1.27K ﹤0.01% 252
2025
Q1
$13.7K Hold
153
﹤0.01% 234
2024
Q4
$12.2K Hold
153
﹤0.01% 232
2024
Q3
$13.8K Hold
153
﹤0.01% 223
2024
Q2
$12K Sell
153
-17
-10% -$1.39K ﹤0.01% 222
2024
Q1
$14.8K Hold
170
﹤0.01% 208
2023
Q4
$14K Hold
170
0.01% 215
2023
Q3
$13.3K Sell
170
-60
-26% -$5.02K 0.01% 211
2023
Q2
$20.3K Buy
230
+60
+35% +$5.17K 0.01% 180
2023
Q1
$13.7K Hold
170
0.01% 192
2022
Q4
$13.2K Hold
170
0.01% 195
2022
Q3
$14K Hold
170
0.01% 161
2022
Q2
$15K Hold
170
0.01% 149
2022
Q1
$19K Hold
170
0.01% 143
2021
Q4
$18K Buy
+170
New +$19.7K 0.01% 140

Other funds holding MDT

Ritter Daniher Financial Advisory's MDT Position: Q2 2026 in Review

Ritter Daniher Financial Advisory reduced its Medtronic (MDT) stake by 4.2% in Q2 2026, selling an estimated $9.2K and leaving 2,597 shares worth $203K. The position accounts for 0.03% of the portfolio, ranked #166.

Ritter Daniher Financial Advisory first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $268K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ritter Daniher Financial Advisory held 2,597 shares of Medtronic worth $203K as of Q2 2026.
  • Ritter Daniher Financial Advisory sold 114 Medtronic shares in Q2 2026, an estimated $9.2K.
  • Medtronic made up 0.03% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #166 holding.
  • Ritter Daniher Financial Advisory first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • Ritter Daniher Financial Advisory's Medtronic position peaked at $268K in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.